Molnupiravir price in India, used in COVID-19 treatment

Molnupiravir 200 mg price

Molnupiravir 200 mg is an antiviral medicine that has been approved by the DGCA (Drug Controller General of India) for emergency use for COVID-19 treatment.

The recommended dose of molnupiravir is 800 mg twice a day for five days. It is a ribonucleoside analogue that impairs the multiplicative ability of SARS-C0V-2 in your body after infection. It was originally developed by Emory University in Atlanta.

Research on molnupiravir suggests the COVID pill will prove effective against mutations of COVID-19 that the CDC classifies as “variants of concern”, including the Delta, Gamma, and Mu mutations.

Molnupiravir capsules 200 mg Molnatris

Molnupiravir trail results

Patients with at least one risk factor for severe infection, such as those over 60 years old, were included in the clinical trial, but “future data will determine whether it may also be used as post-exposure prophylaxis (preventive treatment) in connection with SARS-CoV-2,” according to the researchers.

The MOVe-AHEAD study, a global, multicenter, randomised, double-blind, placebo-controlled Phase 3 trial aiming to test the drug’s safety and efficacy in limiting the transmission of COVID-19 within households, just published its findings.

Molnupiravir reduced the absolute risk of hospitalization and death by 3% and the relative risk by 30%, according to the study. The findings back up molnupiravir’s efficacy in treating mild to moderate COVID-19 in people at high risk of disease progression.

References:

1. Merck Sharp & Dohme (UK) Limited, Electronic medicines compendium (emc), [ Revised on Nov 2021] [ Accessed on 30th Dec 2021], https://www.medicines.org.uk/emc/files/pil.13044.pdf
2. Florain Kabinger et al; Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis; Nature Structural & Molecular Biology; Published on 11/08/2021; Accessed on 30/12/2021; https://www.nature.com/articles/s41594-021-00651-0
3. William Fischer et al; Molnupiravir, an Oral Antiviral Treatment for COVID-19; medRxiv; Published on 17/06/2021; Accessed on 30/12/2021; https://pubmed.ncbi.nlm.nih.gov/34159342/

Uses of Molnupiravir 200mg tablet

• Treatment of coronavirus disease (COVID-19)
• You tested positive for COVID-19
• You have a mil to moderate case of COVID-19
• You`re at high risk of progressing to a severe case of COVID-19 and/or high risk of hospitalization

Doses of molnupiravir 200mg tablet

Molnupiravir dose

Molnupiravir is now prescribed at an oral dose of 800 mg twice a day for five days. Monlupiravir 200 mg is now pursuing approval for non-hospitalized COVID-19 individuals who present with symptoms within five days of start.

This is because recent research suggests that the medication is most successful when started as soon as the virus symptoms appear. It can cut the risk of serious illness that necessitates hospitalization and/or death by up to 50%.

Side effects of molnupiravir 200mg tablet

Molnupiravir side effects

• Nausea
• Diarrhea
• Rashes
• Flu-like symptoms
• Insomnia
• Changes to blood liver tests

Molnupiravir manufacturers in India

Molnupiravir tablet brand name